Background: Canaloplasty is a bleb-independent glaucoma surgery in which Schlemm's canal is dilated with a microcatheter and viscoelastic material, and stretched by a tensioning suture. The suture stent has numerous drawbacks such as the technical challenging implantation, deficient knowledge of proper suture tension, late loosening of the suture, or suture extrusion into the anterior chamber. The Stegmann Canal Expander (SCE) was developed to replace the suture stent and to make canaloplasty easier and more reproducible. The aim of this test was evaluate the usability regarding effectiveness, efficacy, and satisfaction of the implanting ophthalmologist (test person).
Methods: In an experimental setting, the test persons were asked to implant the SCE in human autopsy eyes with a surgically prepared Schlemm's canal by means of surgical instruments and an operating microscope. The standardised test was performed in terms of participant observation with a subsequent opinion survey based on checklist and photographic documentation. Data for a successful handling of the task and qualitative data from the experience of the test person with the product were anonymised, collected and registered in an assessment sheet. The evaluation comprised the aspects of instructions for use, packaging, identification, handling, and implantation of the SCE.
Results: The implantation took 2 to 5 min (mean: 3 min). All questions in the assessment sheet regarding effectiveness, efficacy, and satisfaction (n=35) were answered by all test persons (6/6) with the best category ("completely true"; or "no, no problem").
Conclusions: The usability of the SCE under standardised and experimental conditions regarding effectiveness, efficacy, and satisfaction has been rated as very positive, especially allowing for the fact that some of the ophthalmologists did not have experience in glaucoma surgery or only little experience in ophthalmic surgery.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-0035-1545796 | DOI Listing |
Nanotechnology
January 2025
Nanjing Medical University, Department of Neurosurgery, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Nanjing, 210029, CHINA.
Glioblastoma (GBM) is a malignant tumor with highly heterogeneous and invasive characteristics leading to a poor prognosis. The CD44 molecule, which is highly expressed in GBM, has emerged as a highly sought-after biological marker. Therapeutic strategies targeting the cell membrane protein CD44 have emerged, demonstrating novel therapeutic potential.
View Article and Find Full Text PDFJ Med Internet Res
January 2025
Department of Internal Medicine, Hospital Clinic, Institut d'Investigacio Biomèdica August Pi i Sunyer, Barcelona, Spain.
Background: Enhancing self-management in health care through digital tools is a promising strategy to empower patients with type 2 diabetes (T2D) to improve self-care.
Objective: This study evaluates whether the Greenhabit (mobile health [mHealth]) behavioral treatment enhances T2D outcomes compared with standard care.
Methods: A 12-week, parallel, single-blind randomized controlled trial was conducted with 123 participants (62/123, 50%, female; mean age 58.
Background: Medication-related adverse events are common in pregnant women, and most are due to misunderstanding medication information. The identification of appropriate medication information sources requires adequate medical information literacy (MIL). It is important for pregnant women to comprehensively evaluate the risk of medication treatment, self-monitor their medication response, and actively participate in decision-making to reduce medication-related adverse events.
View Article and Find Full Text PDFDiabetes Care
February 2025
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Objective: To provide an updated synthesis on effects of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) on weight, BMI, and waist circumference incorporating newer randomized controlled trials (RCTs), particularly in individuals with overweight or obesity.
Research Design And Methods: We systematically searched PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) for RCTs published from inception to 4 October 2024. The search was limited to RCTs evaluating the use of GLP-1 RAs for mean differences from baseline in weight, BMI, and waist circumference in adults with obesity or overweight with or without diabetes.
J Speech Lang Hear Res
January 2025
Department of Speech, Language, and Hearing Sciences, The University of Arizona, Tucson.
Purpose: The purpose of this study was to determine if the Vocabulary Acquisition and Usage for Late Talkers (VAULT) intervention could be efficaciously applied to a new treatment target: words a child neither understood nor said. We also assessed whether the type of context variability used to encourage semantic learning (i.e.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!